Get the Stockscreener App
6.75
4.01%
0.26
After Hours:
6.87
0.12
+1.78%
Alpha Cognition Inc stock is traded at $6.75, with a volume of 85,666.
It is up +4.01% in the last 24 hours and up +17.39% over the past month.
Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimers disease, for which there are limited or no treatment options. The Companies current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Companies commercial development program for ZUNVEYL is focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.
See More
Previous Close:
$6.49
Open:
$6.605
24h Volume:
85,666
Relative Volume:
1.19
Market Cap:
$146.98M
Revenue:
$10.22M
Net Income/Loss:
$-20.67M
P/E Ratio:
-5.7354
EPS:
-1.1769
Net Cash Flow:
$-20.72M
1W Performance:
+1.73%
1M Performance:
+17.39%
6M Performance:
-6.64%
1Y Performance:
+46.42%
1-Day Range:
$6.41
$6.97
1-Week Range:
$5.735
$6.97
52-Week Range:
$3.97
$11.54
Alpha Cognition Inc Stock (ACOG) Company Profile
Name
Alpha Cognition Inc
Sector
Industry
Phone
(858) 344-4375
Address
1452 HUGHES RD., STE. 200, GRAPEVINE
Compare ACOG vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ACOG
Alpha Cognition Inc
|
6.75 | 141.31M | 10.22M | -20.67M | -20.72M | -1.1769 |
VRTX
Vertex Pharmaceuticals Inc
|
441.70 | 113.01B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
753.93 | 79.87B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
840.87 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
333.39 | 45.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
319.94 | 34.41B | 5.36B | 287.73M | 924.18M | 2.5229 |
Alpha Cognition Inc Stock (ACOG) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-18-25 | Initiated | H.C. Wainwright | Buy |
Alpha Cognition Inc Stock (ACOG) Latest News
Alpha Cognition Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Caledonian Record
Alpha Cognition Inc. (ACOG) soars 8.6%: Is further upside left in the stock? - MSN
Alpha Cognition Inc enters settlement agreement with Galantos Pharma on April 10, 2026SEC filing - marketscreener.com
Alpha Cognition IncEnters Settlement Agreement With Galantos Pharma On April 10, 2026SEC Filing - TradingView — Track All Markets
[8-K] Alpha Cognition Inc. Reports Material Event - Stock Titan
Alpha Cognition Earnings Call: Early Traction, Rising Costs - TipRanks
Is Alpha Cognition Inc a strong candidate for buy and hold2026 Macro Moves & Safe Entry Trade Reports - baoquankhu1.vn
Aug Reactions: Whats the MACD signal for Alpha Cognition Inc2026 Closing Moves & Weekly High Conviction Trade Ideas - baoquankhu1.vn
Aug Swings: Will Alpha Cognition Inc announce a stock splitMarket Volume Summary & Stock Timing and Entry Methods - baoquankhu1.vn
Sell Signal: What are the analyst revisions for BBAIWSIs Alpha Cognition Inc stock a good investment in YEARGap Up & Daily Entry Point Trade Alerts - baoquankhu1.vn
Portfolio Recap: What are the analyst revisions for BBAIWSIs Alpha Cognition Inc stock a good investment in YEAR2026 Key Highlights & Verified Short-Term Trading Plans - baoquankhu1.vn
Alpha Cognition Inc (OTC:ACOGF) Stock Quote - The Chronicle-Journal
Movement Recap: Can Alpha Cognition Inc stock double in the next yearMarket Trend Summary & AI Powered Market Entry Ideas - baoquankhu1.vn
Alpha Cognition (NASDAQ:ACOG) Lowered to "Sell" Rating by Wall Street Zen - MarketBeat
Alpha Cognition Inc. (ACOG) Jumps 8.6%: Does the Stock Have More Room to Grow? - Bitget
Alpha Cognition Inc. (ACOG) Soars 8.6%: Is Further Upside Left in the Stock? - Yahoo Finance
Alpha Cognition Receives Issued U.S. Patent for ALPHA-1062 for Treatment of Traumatic Brain Injury - BioSpace
Opaleye Management Inc. Increases Stake in Alpha Cognition Inc. - GuruFocus
Alpha Cognition receives U.S. patent for traumatic brain injury drug By Investing.com - Investing.com Australia
Alpha Cognition receives issued U.S. patent for Alpha-1062 for treatment of traumatic brain injury - marketscreener.com
Alpha Cognition Receives Issued U.S. Patent For Alpha-1062 For Treatment Of Traumatic Brain Injury - TradingView — Track All Markets
Alpha Cognition receives U.S. patent for traumatic brain injury drug - Investing.com
Alpha Cognition Gets US Patent for ALPHA-1062 in Traumatic Brain Injury - marketscreener.com
Alpha Cognition Reports Strong ZUNVEYL Adoption in Long-Term Care Facilities - citybuzz -
Stonegate Capital Partners Updates Coverage on Alpha Cognition Inc. (ACOG) Q425 - Nasdaq
Alpha Cognition (ACOG) Q4 2025 Earnings Transcript - The Globe and Mail
EV Market: Will Alpha Cognition Inc benefit from geopolitical trendsQuarterly Portfolio Report & Weekly High Potential Stock Alerts - baoquankhu1.vn
Alpha Cognition (NASDAQ: ACOG) outlines ZUNVEYL launch, $44M license and Alzheimer’s pipeline - Stock Titan
Opaleye fund adds Alpha Cognition (ACOG) stake with new share purchases - Stock Titan
Aug PreEarnings: Does Alpha Cognition Inc have declining or rising EPS2026 Geopolitical Influence & Technical Pattern Recognition Alerts - baoquankhu1.vn
Can Alpha Cognition Inc outperform under higher oil prices2026 AllTime Highs & Risk Controlled Stock Pick Alerts - baoquankhu1.vn
Alpha Cognition Reports Q4 Earnings, Highlights Continued ZUNVEYL Growth - National Today
Alpha Cognition (NASDAQ:ACOG) Posts Earnings Results, Misses Estimates By $0.03 EPS - marketbeat.com
Alpha Cognition Inc. Announces 2026 Annual General Meeting Date and Details for Security Holders - Minichart
Alpha Cognition Q4 Earnings Call Highlights - Defense World
Alpha Cognition schedules annual shareholder meeting for June 16 - uk.investing.com
Alpha Cognition schedules annual shareholder meeting for June 16 By Investing.com - Investing.com India
Alpha Cognition (NASDAQ: ACOG) sets June 16, 2026 annual shareholder meeting - Stock Titan
Alpha Cognition Inc. Common Stock Q4 2025 Earnings Call Summary - Yahoo Finance
Alpha Cognition reports Q4 revenue of $2.5M for Alzheimer’s drug - Investing.com Australia
Major Investor Quietly Boosts Stake in Alpha Cognition Inc. - TipRanks
Alpha Cognition Q4 2025 Earnings Call Transcript - MarketBeat
Alpha Cognition Inc. (ACOG) reports Q4 loss, lags revenue estimates - MSN
Alpha Cognition Inc Stock (ACOG) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.69%
0.25%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):